首页|Th17/Treg细胞与高血压相关性的研究现状

Th17/Treg细胞与高血压相关性的研究现状

扫码查看
高血压作为一种常见的慢性疾病,其发病率在全球范围内逐年上升,且病理机制复杂,涉及遗传、环境、生活方式等多种因素.近年来,免疫-炎症机制在高血压发病中的作用逐渐受到关注.特别是辅助性T细胞17(Th17)和调节性T细胞(Treg),作为免疫系统中的重要组成部分,其平衡状态对高血压的影响成为研究热点.本文将对Th17/Treg与高血压相关性的研究进展进行综述,为高血压的免疫治疗和预防提供新的思路和方法.
Research status of the relationship between Th17/Treg cells and hypertension
Hypertension is a common chronic disease,and its incidence is increasing year by year worldwide.Its pathological mechanism is complex,involving genetics,environment,lifestyle and other factors.In recent years,the role of immune-inflammatory mechanism in the pathogenesis of hypertension has gradually attracted attention.Especially T helper cell 17(Th17)and regulatory T cells(Treg),as important components of the immune system,the effect of their balance on hypertension has become a research hotspot.This article reviews the research progress of the correlation between Th17/Treg and hypertension,in order to provide new ideas and methods for the immunotherapy and prevention of hypertension.

T helper cell 17regulatory T cellhigh blood pressure

龚玉栓、王倩、魏惠平

展开 >

甘肃中医药大学中西医结合学院,甘肃兰州 730000

甘肃中医药大学附属医院心血管科,甘肃兰州 730020

辅助性T细胞17 调节性T细胞 高血压

甘肃省自然科学基金资助项目甘肃省中医药管理局课题资助项目甘肃中医药大学附属医院院内创新基金资助项目

21JR7RA581GZKZ-2020-9KC2018-18

2024

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子:1.91
ISSN:1001-6821
年,卷(期):2024.40(20)